Skip to main content
Watch Insiders
Market intelligence
GDTCSector not reported

CytoMed Therapeutics Ltd insider activity

In the last 90 days, 1 corporate insider purchased $300,000 of stock on the open market.

SEC-reported filing activity is provided for research purposes and is not investment advice.

90-day C-suite buyers
0
90-day purchase value
$300,000
Corporate buyers
1
Latest transaction
Jul 20, 2026

Executive filings

Open-market transaction history

Purchase and sale summaries are ordered by the latest reported transaction date.

Open-market insider purchase and sale transactions
DateInsider nameRoleTypeSharesPriceTotal value
Jul 20, 2026Chee Kong ChooCorporate insiderOpen Market Purchase200,000$1.50$300,000
May 13, 2026Chee Kong ChooCorporate insiderOpen Market Purchase112,000$1.15$128,778